The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases

  1. Aaron W Jurrjens
  2. Marcus M Seldin
  3. Corey Giles
  4. Peter J Meikle
  5. Brian G Drew  Is a corresponding author
  6. Anna C Calkin  Is a corresponding author
  1. Baker Heart and Diabetes Institute, Australia
  2. Central Clinical School, Monash University, Australia
  3. Department of Biological Chemistry and Center for Epigenetics and Metabolism, University of California, Irvine, United States
  4. Baker Department of Cardiometabolic Health, University of Melbourne, Australia
  5. Baker Department of Cardiovascular Research Translation and Implementation, La Trobe University, Australia

Peer review process

This article was accepted for publication as part of eLife's original publishing model.

History

  1. Version of Record published
  2. Accepted
  3. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Aaron W Jurrjens
  2. Marcus M Seldin
  3. Corey Giles
  4. Peter J Meikle
  5. Brian G Drew
  6. Anna C Calkin
(2023)
The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases
eLife 12:e86139.
https://doi.org/10.7554/eLife.86139

Share this article

https://doi.org/10.7554/eLife.86139